GlaxoSmithKline Settles Avandia Drug Heart Attack Death Suit on Eve of First Trial

Drugmaker GlaxoSmithKline has settled out of court just before a trial alleging its Avandia diabetes drug caused a man to die of a heart attack. The settlement means that the company has avoided a jury determination over risks associated with the medicine.

The company did not provide and details of the settlement, which eliminates the risk that GlaxoSmithKline would face a large jury award.

Bloomberg reports:

"The lawsuit ... was the first of 2,000 heading to court alleging ... Glaxo hid Avandia's health risks. Regulators in Europe had the drug withdrawn from the market and U.S. sales were limited because of heart attack risks."

+ Sources and References
Post your comment
Click Here and be the first to comment on this article